Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01907789 · ClinicalTrials.gov registry record · NA

Prophylactic Salpingectomy With Delayed Oophorectomy

A NA study of Ovarian Carcinoma, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
80
Enrollment target
2
Study locations

NCT01907789 is a NA study of Ovarian Carcinoma that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 80 participants, below the 3,242-participant average among 35 other Ovarian Carcinoma trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01907789, a NA study of Ovarian Carcinoma, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
80 participants
Enrollment target
2
Study locations

Study Summary

The goal of this clinical research study is to compare ovarian cancer screening, risk-reducing salpingo-oophorectomy (RRSO), and prophylactic salpingectomy with delayed oophorectomy (PSDO). The safety of RRSO and PSDO will also be studied. Ovarian cancer screening does not involve a surgical procedure. Instead, physical exams, blood tests, and ultrasound are used to check for ovarian, fallopian tube, and peritoneal cancer. The surgical procedures, RRSO and PSDO, are designed to lower your risk of ovarian cancer. In RRSO, the fallopian tubes and ovaries are removed at the same time. In PSDO, the fallopian tubes are removed and the ovaries remain in place so that the patient does not go through menopause. The ovaries are removed at a later date. The main goal of this study is to learn how many patients actually have their ovaries removed at a later date. Researchers also want to learn whether the removal of fallopian tubes will decrease the risk of ovarian cancer.

Conditions Studied

Ovarian Carcinoma

Interventions

  • BEHAVIORAL Questionnaire
  • PROCEDURE Transvaginal Ultrasound
  • OTHER Ovarian Cancer Screening
  • PROCEDURE Prophylactic Salpingectomy with Delayed Oophorectomy
  • PROCEDURE Risk-Reducing Salpingo-Oophorectomy

Study Locations (2)

Illinois

  • NorthShore University Health System - Evanston

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 80 participants
Start Date 2013-08-26
Est. Completion 2030-12-31
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01907789

The ClinicalTrials.gov registry entry for NCT01907789 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,242-participant average among 35 other Ovarian Carcinoma trials with a reported enrollment target (98% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Ovarian Carcinoma appearing as the primary indexed condition, and to 5 interventions - of which Questionnaire is the first listed.

NCT01907789 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Illinois, Texas.

Frequently Asked Questions

What is clinical trial NCT01907789 about?

NCT01907789 is a clinical study titled "Prophylactic Salpingectomy With Delayed Oophorectomy". The goal of this clinical research study is to compare ovarian cancer screening, risk-reducing salpingo-oophorectomy (RRSO), and prophylactic salpingectomy with delayed oophorectomy (PSDO). The safety of RRSO and PSDO will also be studied. Ovarian cancer screening does not involve a surgical proced...

What is the current status of trial NCT01907789?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 80 participants. The study started on 2013-08-26. Estimated completion is 2030-12-31.

What conditions does trial NCT01907789 study?

This clinical trial studies the following conditions: Ovarian Carcinoma.

What interventions are being tested in trial NCT01907789?

The interventions under investigation include: Questionnaire (BEHAVIORAL), Transvaginal Ultrasound (PROCEDURE), Ovarian Cancer Screening (OTHER), Prophylactic Salpingectomy with Delayed Oophorectomy (PROCEDURE), Risk-Reducing Salpingo-Oophorectomy (PROCEDURE).

Who is sponsoring clinical trial NCT01907789?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01907789 being conducted?

This trial has 2 study locations across Illinois, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Ovarian Carcinoma

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Ovarian Carcinoma

All registered trials for this condition

Illinois

All trials with a study site in Illinois

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.